|
Volumn 111, Issue 4, 2013, Pages 609-612
|
Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOXORUBICIN;
ADULT;
ARTICLE;
CANCER REGRESSION;
CANCER SURVIVOR;
CAUSE OF DEATH;
CONGESTIVE CARDIOMYOPATHY;
DRUG INDUCED DISEASE;
FEMALE;
HEART FAILURE;
HEART TRANSPLANTATION;
HUMAN;
LONG TERM SURVIVAL;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT OUTCOME;
ADULT;
CARDIOMYOPATHY, DILATED;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
HEART TRANSPLANTATION;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MALE;
MIDDLE AGED;
NEOPLASMS;
REGISTRIES;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SURVIVAL RATE;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 84873291022
PISSN: 00029149
EISSN: 18791913
Source Type: Journal
DOI: 10.1016/j.amjcard.2012.10.048 Document Type: Article |
Times cited : (62)
|
References (6)
|